Grzeczka, A.; Pasławska, U.; Graczyk, S.; Antosik, P.; Zawadzki, M.; Pasławski, R.
Pulmonary Hypertension Secondary to Myxomatous Mitral Valve Disease in Dogs: Current Insights into the Histological Manifestation and Its Determining Factors. Appl. Sci. 2024, 14, 2577.
https://doi.org/10.3390/app14062577
AMA Style
Grzeczka A, Pasławska U, Graczyk S, Antosik P, Zawadzki M, Pasławski R.
Pulmonary Hypertension Secondary to Myxomatous Mitral Valve Disease in Dogs: Current Insights into the Histological Manifestation and Its Determining Factors. Applied Sciences. 2024; 14(6):2577.
https://doi.org/10.3390/app14062577
Chicago/Turabian Style
Grzeczka, Arkadiusz, Urszula Pasławska, Szymon Graczyk, Paulina Antosik, Marcin Zawadzki, and Robert Pasławski.
2024. "Pulmonary Hypertension Secondary to Myxomatous Mitral Valve Disease in Dogs: Current Insights into the Histological Manifestation and Its Determining Factors" Applied Sciences 14, no. 6: 2577.
https://doi.org/10.3390/app14062577
APA Style
Grzeczka, A., Pasławska, U., Graczyk, S., Antosik, P., Zawadzki, M., & Pasławski, R.
(2024). Pulmonary Hypertension Secondary to Myxomatous Mitral Valve Disease in Dogs: Current Insights into the Histological Manifestation and Its Determining Factors. Applied Sciences, 14(6), 2577.
https://doi.org/10.3390/app14062577